ARCHIVES

UK’s NICE Set to Deny Payments For Zaltrap In Second-Line Metastatic Colorectal Cancer

This article is from The Cancer Letter archive.

Vol. 39 No. 26 | June 26, 2013

Download PDF Visit The Full Archive

Related Articles

Celecoxib Effective To Prevent Colon Adenomas, Study Finds

April 25, 2008

ODAC Votes Against Adria’s Chemoprotector, Okays Leustatin

July 3, 1992

Research Funding In Crisis; Scientists Fear Cancer Program’s Dismantling, AACR Says

January 20, 1995

Biotherapeutics Reports LAK/IL-2 Toxicity Reduced With Constant Infusion Of IL-2

April 17, 1987

Does a B from USPSTF Guarantee Coverage? Lung Screening will Define Medicare Stance

March 21, 2014

NCI CTEP Approved Trials For the Month of July

July 26, 2013